India · Delayed Price · Currency is INR Alembic Pharmaceuticals Statistics
Total Valuation
BOM:533573 has a market cap or net worth of INR 151.33 billion. The enterprise value is 164.76 billion.
| Market Cap | 151.33B |
| Enterprise Value | 164.76B |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
| Current Share Class | 196.56M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.41% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 5.53% |
| Owned by Institutions (%) | 17.29% |
| Float | 57.86M |
Valuation Ratios
The trailing PE ratio is 24.06 and the forward PE ratio is 18.93.
| PE Ratio | 24.06 |
| Forward PE | 18.93 |
| PS Ratio | 2.08 |
| PB Ratio | 2.85 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.20 |
| EV / Sales | 2.27 |
| EV / EBITDA | 14.39 |
| EV / EBIT | 19.11 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.30 |
| Debt / FCF | n/a |
| Interest Coverage | 9.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 10.58% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 4.39M |
| Profits Per Employee | 379,555 |
| Employee Count | 16,571 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:533573 has paid 1.41 billion in taxes.
| Income Tax | 1.41B |
| Effective Tax Rate | 18.42% |
Stock Price Statistics
The stock price has decreased by -6.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.67% |
| 50-Day Moving Average | 819.65 |
| 200-Day Moving Average | 918.36 |
| Relative Strength Index (RSI) | 36.69 |
| Average Volume (20 Days) | 3,686 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:533573 had revenue of INR 72.67 billion and earned 6.29 billion in profits. Earnings per share was 32.07.
| Revenue | 72.67B |
| Gross Profit | 51.96B |
| Operating Income | 8.64B |
| Pretax Income | 7.67B |
| Net Income | 6.29B |
| EBITDA | 11.27B |
| EBIT | 8.64B |
| Earnings Per Share (EPS) | 32.07 |
Balance Sheet
The company has 1.43 billion in cash and 14.89 billion in debt, with a net cash position of -13.46 billion.
| Cash & Cash Equivalents | 1.43B |
| Total Debt | 14.89B |
| Net Cash | -13.46B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 53.16B |
| Book Value Per Share | 270.70 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.51%, with operating and profit margins of 11.88% and 8.66%.
| Gross Margin | 71.51% |
| Operating Margin | 11.88% |
| Pretax Margin | 10.56% |
| Profit Margin | 8.66% |
| EBITDA Margin | 15.51% |
| EBIT Margin | 11.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.38%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.41% |
| Shareholder Yield | 1.79% |
| Earnings Yield | 4.16% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |